期刊文献+

GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用 被引量:2

Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus
原文传递
导出
摘要 2型糖尿病是诱发阿尔茨海默病的高危因素。胰高血糖素样肽-1(GLP-1)可诱导胰岛β细胞再生和增殖,可以呈葡萄糖依赖性地促进胰岛素分泌。另外,GLP-1在治疗神经退行性病变中也有重要的作用,能降低脑内β淀粉样蛋白斑块沉积,减少氧化应激引起的神经细胞损伤,还可以调节突触的传递,增加突触的可塑性,刺激轴突生长,影响长时程增强,从而改善记忆并提高认知水平。 Type 2 diabetes has been identified as a risk factor for Alzheimer's disease (AD). Glu- cagon-like peptide-1 ( GLP-1 ) can stimulate 13 cell proliferation and insulin secretion in a glucose-dependent manner. It has been shown that GLP-1 also plays important roles in the treatment of neurodegenerative dis- ease, such as reversing the detrimental effects that 13-amyloid plaque load in brain, preventing neurons from oxidative damage, modulating synaptic transmission, rescuing synaptic plasticity, stimulating neurite growth, and affecting the process of long-term potentiation. Thus it can improve memory and cognitive dysfunction.
出处 《国际内分泌代谢杂志》 2016年第1期48-51,共4页 International Journal of Endocrinology and Metabolism
关键词 胰高血糖素样肽-1 2型糖尿病 阿尔茨海默病 Glucagon-like peptide-1 Type 2 diabetes mellitus Alzheimer's disease
  • 相关文献

参考文献28

  • 1Ott A, Stolk RP, van Harskamp F,et al. Diabetes mellitus and the risk of dementia: The Rotterdam Study[ J]. Neurology, 1999, 53(9) :1937-1942.
  • 2Mclntyre RS, Powell AM, Kaidanovich-Beilin O,et al. The neu- roprotective effects of GLP-I: possible treatments for cognitive deficits in individualswith mood disorders [ J ]. Behav Brain Res, 2013,237 : 164-171. DOI : 10. 1016/j. bbr. 2012.09. 021.
  • 3Ling X, Martins RN, Racchi M,et al. Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor [ J ]. J Alzheimers Dis, 2002,4 ( 5 ) : 369 -374.
  • 4Plastino M, Fava A, Pi'itano D,et al. Effects of insulinic thera- py on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2 [ J]. J Neurol Sci, 2010, 288 ( 1-2 ) : I 12-116. DOI: 10. I016/j. j ns. 2009.09. 022.
  • 5Gispen WH, Biessels GJ. Cognition and synaptic plasticity in di- abetes mellitus[ J]. Trends Neurosci, 2000,23:542-549.
  • 6Dukie-Stefanovic S,Schinzel R, Riederer P, et al. AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs [ J ]. Biogerontology ,2001,2 ( 1 ) : 19-34.
  • 7Yan SD, Roher A, Chancy M,et al. Cellular cofactors potentia- ting induction of stress and cytotoxicity by amyloid beta-peptide [ J ]. Biochim Biopbys Acta,2000,1502 ( 1 ) : 145-157.
  • 8Sasaki N, Toki S, Chowei H, et al. lmmunohistochemical distri- bution of the receptor for advanced glycation end products in neu- rons and astrocytes in Alzheimer's disease [ J ]. Brain Res, 2001, 888 : 256-262.
  • 9Beeri MS, Moshier E, Sehmeidler J,et al. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with in- creased cognitive decline in elderly individuals[ J]. Mech Ageing Dev,2011,132 ( 11-12 ) :583-587. DOI : 10. 1016/j. mad. 2011. 10. 007.
  • 10Fawver JN, Schall HE, Petrofes Chapa RD, et al. Amyloid-me- tabolite sensing: biochemical linking of glycation modification and misfolding[ J]. J Alzheimer Disease,2012, 30 : 63-73. DOI : 10. 3233/JAD-2012-112114.

同被引文献20

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部